Pricing Log in Create free account

Ensysce Biosciences, Inc. (ENSC) vs MetaVia Inc. (MTVA)

Ensysce Biosciences, Inc. and MetaVia Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and MetaVia Inc. are of similar size ($7.2M and $7.0M). MetaVia Inc. has the higher net margin (0.00% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, MetaVia Inc. leads on 9 and Ensysce Biosciences, Inc. on 1.

Valuation

Metric ENSC MTVA Biotechnology median
P/E n/m n/m 10.60
P/S 0.98 n/m 9.40
P/B n/m 1.22 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.04 0.66
EV/Sales 1.01 n/m 9.02
Earnings yield (811.76%) (285.73%) (32.88%)
Free cash flow yield (199.80%) (190.70%) (23.13%)

Profitability

Metric ENSC MTVA Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (281.32%) 0.00% 0.00%
Net margin (280.49%) 0.00% 0.00%
Free cash flow margin (196.76%) 0.00% 0.00%
Return on equity (1,295.01%) (175.68%) (51.96%)
Return on assets (295.92%) (91.06%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENSC MTVA Biotechnology median
Revenue growth (TTM) (39.29%) — 6.76%
EPS growth (last fiscal year) 65.24% 81.23% 29.88%
Revenue growth, 5-year CAGR 5.21% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENSC MTVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.70 2.06 4.97
Net debt to EBITDA 0.42 0.75 1.01

Dividend

Metric ENSC MTVA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENSC MTVA Biotechnology median
Market cap 7.02m 7.18m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack